Respiratory Oxygen Delivery Devices Market Report 2026

Respiratory Oxygen Delivery Devices Market Overview

• Respiratory Oxygen Delivery Devices market size has reached to $16.53 billion in 2025 • Expected to grow to $25.69 billion in 2030 at a compound annual growth rate (CAGR) of 8.9% • Growth Driver: Driving Factors Behind The Growth Of The Respiratory Oxygen Delivery Device Market • Market Trend: Smart Sensor-Enabled and Connected Oxygen Concentrators Enhancing Patient Monitoring • Asia-Pacific was the largest region in 2025.

What Is Covered Under Respiratory Oxygen Delivery Devices Market?

Respiratory oxygen delivery devices are medical tools designed to deliver oxygen to patients who require supplemental oxygen therapy to support their breathing. They are utilized to provide oxygen therapy to individuals with respiratory conditions such as chronic obstructive pulmonary disease (COPD), pneumonia, and other lung diseases, as well as those experiencing hypoxemia (low oxygen levels in the blood) due to various medical conditions or environmental factors. The main product types of respiratory oxygen delivery devices are oxygen masks, nasal cannulas, ventilator masks, non-rebreather masks, bag valve masks, continuous positive airway pressure (CPAP) masks, and others. Oxygen masks are medical devices designed to deliver oxygen to patients by covering the nose and mouth, allowing for the inhalation of oxygen-enriched air. Devices are used in applications such as chronic obstructive pulmonary disease (COPD), asthma, cystic fibrosis, respiratory distress syndrome, pneumonia, and others by end users, including hospitals, outpatient facilities, and home care.

What Is The Respiratory Oxygen Delivery Devices Market Growth Forecast?

The respiratory oxygen delivery devices market size is expected to see strong growth in the next few years. It will grow to $25.69 billion in 2030 at a compound annual growth rate (CAGR) of 8.9%. The growth in the forecast period can be attributed to increasing adoption of remote patient monitoring, rising demand for home healthcare services, growing focus on early respiratory disease management, expansion of smart connected medical devices, increasing investments in respiratory care technologies. Major trends in the forecast period include increasing adoption of high-flow oxygen delivery systems, rising demand for home-based oxygen therapy devices, growing integration of smart oxygen monitoring features, expansion of portable and lightweight oxygen devices, enhanced focus on patient comfort and compliance.

Global Respiratory Oxygen Delivery Devices Market Segmentation

1) By Product: Oxygen Masks, Nasal Cannula, Venturi Masks, Non-rebreather Masks, Bag Valve Masks, Continuous Positive Airway Pressure (CPAP) Masks, Other Products 2) By Application: Chronic Obstructive Pulmonary Disease (COPD), Asthma, Cystic Fibrosis, Respiratory Distress Syndrome, Pneumonia, Other Disease Applications 3) By End-Use: Hospitals, Outpatient Facilities, Home Care Subsegments: 1) By Oxygen Masks: Simple Oxygen Masks, Partial Rebreather Masks 2) By Nasal Cannula: Standard Nasal Cannula, High-Flow Nasal Cannula 3) By Venturi Masks: Fixed Venturi Masks, Adjustable Venturi Masks 4) By Non-Rebreather Masks: Adult Non-Rebreather Masks, Pediatric Non-Rebreather Masks 5) By Bag Valve Masks: Adult Bag Valve Masks, Pediatric Bag Valve Masks 6) By Continuous Positive Airway Pressure (Cpap) Masks: Full-Face Cpap Masks, Nasal Cpap Masks 7) By Other Products: Oxygen Concentrators, Oxygen Cylinders

What Is The Driver Of The Respiratory Oxygen Delivery Devices Market?

The increasing prevalence of asthma is expected to propel the growth of the respiratory oxygen delivery device market going forward. Asthma is a chronic respiratory condition characterized by inflammation and narrowing of the airways, leading to recurring episodes of wheezing, coughing, chest tightness, and shortness of breath. The cases of asthma are on the rise due to air pollution, allergen exposure, genetic predisposition, changes in lifestyle and dietary habits, and urbanization. Respiratory oxygen delivery devices help in managing asthma by providing supplemental oxygen therapy to patients during exacerbations, ensuring adequate oxygenation, and alleviating symptoms, thus improving respiratory function and enhancing the quality of life for individuals with asthma. For instance, in October 2024, according to the National Asthma Council, an Australia-based non-profit organization, in 2023, Australia recorded a total of 474 asthma-related deaths, comprising 325 females and 149 males. This figure is almost identical to the 473 asthma-related deaths reported in 2022, highlighting a consistent trend in asthma mortality over the two years. Therefore, an increasing prevalence of asthma is driving the respiratory oxygen delivery devices industry.

Key Players In The Global Respiratory Oxygen Delivery Devices Market

Major companies operating in the respiratory oxygen delivery devices market are Medtronic plc, Air Liquide S.A., Becton Dickinson And Company, Koninklijke Philips N.V., GE HealthCare Technologies Inc., Medline Industries Inc., ResMed Inc., Drägerwerk AG And Co. KGaA, Smiths Group, Teleflex Incorporated, Masimo Corporation, Chart Industries Inc., Fisher And Paykel Healthcare Limited, Invacare Corporation, Vyaire Medical Inc., Inogen Inc., Drive DeVilbiss Healthcare Inc., Hamilton Medical AG, GaleMed Corporation, Weinmann Emergency Medical Technology GmbH And Co. KG, Precision Medical Inc., Allied Healthcare Products Inc., Salter Labs Inc.

Global Respiratory Oxygen Delivery Devices Market Trends and Insights

Major companies operating in the respiratory oxygen delivery device market are focusing on integrating advanced sensor control systems and connectivity features to improve patient monitoring and therapy outcomes. Advanced sensor control systems and connectivity features refer to technologies in devices that monitor and adjust performance automatically using sensors, while also enabling remote access, data sharing, and real-time communication through wireless or network connections. For instance, in October 2024, Inogen, Inc., a US-based medical device company, launched its Rove 4 portable oxygen concentrator, which features Bluetooth connectivity via the Inogen Connect app. This app allows users to remotely monitor oxygen purity, battery life, and flow settings directly from their smartphones, highlighting the industry's shift towards connected, high-efficiency PSA-based oxygen devices for real-time tracking and smarter home therapy.

What Are Latest Mergers And Acquisitions In The Respiratory Oxygen Delivery Devices Market?

In February 2023, React Health Inc., a US-based manufacturer and distributor of medical devices for the treatment of sleep-disordered breathing and oxygen therapy, acquired a respiratory product line from Invacare Holdings Corporation for an undisclosed amount. The acquisition expands React Health's product range to include critical respiratory devices, bolstering its position in the medical device market, especially in sleep-disordered breathing and oxygen therapy treatments. Invacare Holdings Corporation is a US-based manufacturing company specializing in respiratory therapy medical equipment, including stationary oxygen concentrators and oxygen refilling devices.

Regional Outlook

Asia-Pacific was the largest region in the respiratory oxygen delivery devices market in 2025. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain

What Defines the Respiratory Oxygen Delivery Devices Market?

The respiratory oxygen delivery devices market consists of sales of nasal cannulas, oxygen masks, oxygen concentrators, and oxygen cylinders. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.